Publicacións nas que colabora con Mónica Olivares Martín (14)

2022

  1. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial

    Frontiers in Nutrition, Vol. 9

2021

  1. Effects of a Combination of Extracts from Olive Fruit and Almonds Skin on Oxidative and Inflammation Markers in Hypercholesterolemic Subjects: A Randomized Controlled Trial

    Journal of Medicinal Food, Vol. 24, Núm. 5, pp. 479-486

  2. Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: An open-label, parallel, randomised, controlled trial

    Beneficial Microbes, Vol. 12, Núm. 1, pp. 55-67

2020

  1. Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women

    Beneficial microbes, Vol. 11, Núm. 3, pp. 235-244

  2. Effects of a combination of elderberry and reishi extracts on the duration and severity of respiratory tract infections in elderly subjects: A randomized controlled trial

    Applied Sciences (Switzerland), Vol. 10, Núm. 22, pp. 1-11

  3. High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial

    Gynecological Endocrinology, Vol. 36, Núm. 5, pp. 398-401

2019

  1. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial

    Gynecological Endocrinology, Vol. 35, Núm. 8, pp. 695-700

  2. Effects of Lactobacillus coryniformis K8 CECT5711 on the immune response to influenza vaccination and the assessment of common respiratory symptoms in elderly subjects: a randomized controlled trial

    European Journal of Nutrition, Vol. 58, Núm. 1, pp. 83-90

  3. Lactobacillus reuteri v3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study

    Nutrients, Vol. 11, Núm. 8

2018

  1. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: A randomized clinical trial (PROSIR)

    BMC Complementary and Alternative Medicine, Vol. 18, Núm. 1

2017

  1. A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota

    Molecular Nutrition and Food Research, Vol. 61, Núm. 8

  2. Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial

    Breastfeeding Medicine, Vol. 12, Núm. 4, pp. 202-209

2015

  1. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial

    Pharmacological Research, Vol. 95-96, pp. 12-19

2014

  1. A genetic variant of PPARA modulates cardiovascular risk biomarkers after milk consumption

    Nutrition, Vol. 30, Núm. 10, pp. 1144-1150